Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Erlotinib can cause persistent excessive hair growth.

A new mutation in the KRT86 gene causes monilethrix in a Han family.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

HPV8 causes skin cancer by expanding specific skin stem cells.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Lhx2 is a crucial regulator of the Sonic Hedgehog signaling in early mouse retinal development.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Nestin is found in hair follicle progenitor cells, linking them to neural stem cells.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Apocrine type cutaneous mixed tumors often resemble hair follicles, sebaceous glands, and apocrine glands.

A unique gene mutation was found in a family with monilethrix.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Including androgens in hormone therapy may lower breast cancer risk.

Hyperthyroidism can hide signs of high androgen levels in females.